US Stock MarketDetailed Quotes
BCTX BriaCell Therapeutics
- 0.982
- +0.140+16.63%
Close Nov 29 13:00 ET
- 0.960
- -0.022-2.28%
Post 16:05 ET
35.55MMarket Cap-3387P/E (TTM)
1.010High0.850Low1.52MVolume0.850Open0.842Pre Close1.42MTurnover4.79%Turnover RatioLossP/E (Static)36.18MShares5.97052wk High-14.88P/B31.10MFloat Cap0.46452wk Low--Dividend TTM31.65MShs Float12.470Historical High--Div YieldTTM19.00%Amplitude0.464Historical Low0.939Avg Price1Lot Size
BriaCell Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1.61%-24.13M | 63.04%-4.04M | 4.65%-5.08M | -87.29%-7.4M | -114.69%-7.61M | -90.20%-23.74M | -228.32%-10.92M | -10.53%-5.33M | -54.59%-3.95M | -99.17%-3.54M |
| Net income from continuing operations | 75.71%-4.93M | 48.37%-1.25M | 134.57%1.69M | 4.61%-11.33M | 638.51%5.96M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M | -206.46%-11.88M | 95.98%-1.11M |
| Operating gains losses | -1,227.46%-28.14M | 11.01%-4.53M | -1,922.27%-10.91M | -79.21%1.59M | -246.84%-14.28M | -118.18%-2.12M | -7.73%-5.09M | -109.10%-539.43K | 151.56%7.63M | -116.31%-4.12M |
| Depreciation and amortization | 449.39%83.9K | 1,797.43%72.44K | -0.05%3.82K | 0.05%3.82K | 0.00%3.82K | -0.01%15.27K | -0.03%3.82K | 0.03%3.82K | -0.05%3.82K | 0.03%3.82K |
| Change In working capital | 299.70%7.05M | 132.79%1.29M | 2,154.47%3.74M | 6,070.75%1.84M | -68.15%180.33K | -802.65%-3.53M | -507.17%-3.95M | 88.66%-181.88K | -88.77%29.86K | 2,664.38%566.19K |
| -Change in receivables | -14,107.23%-732.58K | -18,411.89%-736.22K | 349.87%14.91K | -142.06%-8.74K | 54.66%-2.54K | 145.36%5.23K | 58.45%-3.98K | -147.24%-5.97K | 365.02%20.77K | 17.17%-5.6K |
| -Change in prepaid assets | 148.35%2.13M | 130.43%1.33M | 199.96%888.22K | -428.26%-1.03M | 74.05%937.82K | -475.56%-4.4M | -1,179.51%-4.36M | 35.52%-888.59K | 212.99%312.73K | 389.37%538.82K |
| -Change in payables and accrued expense | 557.82%5.66M | 68.13%703.4K | 297.57%2.83M | 1,047.78%2.88M | -2,390.30%-754.95K | 123.88%860.37K | -27.22%418.36K | 398.37%712.68K | -274.72%-303.64K | 126.28%32.96K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1.61%-24.13M | 63.04%-4.04M | 4.65%-5.08M | -87.29%-7.4M | -114.69%-7.61M | -90.20%-23.74M | -228.32%-10.92M | -10.53%-5.33M | -54.59%-3.95M | -99.17%-3.54M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -681.8K | -456.8K | -225K | 0 | 0 | 0 | ||||
| Net PPE purchase and sale | ---456.8K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net business purchase and sale | ---225K | --0 | ---225K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---681.8K | ---456.8K | ---225K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 11.75%4.42M | 10.47%4.42M | 0 | 0 | 0 | 205.65%3.95M | 2,603.40%4M | -99.88%1.59K | 0 | -47.29K |
| Net common stock issuance | 11.79%4.42M | 10.47%4.42M | --0 | --0 | --0 | 138.86%3.95M | 3,996.09%4M | --0 | --0 | ---47.29K |
| Proceeds from stock option exercised by employees | --0 | --0 | ---- | ---- | ---- | -99.98%1.59K | --0 | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 11.75%4.42M | 10.47%4.42M | --0 | --0 | --0 | 205.65%3.95M | 2,603.40%4M | -99.88%1.59K | --0 | ---47.29K |
| Net cash flow | ||||||||||
| Beginning cash position | -48.22%21.25M | -96.68%935.69K | -81.36%6.24M | -63.56%13.65M | -48.22%21.25M | -28.33%41.04M | -36.74%28.17M | -30.18%33.5M | -32.51%37.45M | -28.33%41.04M |
| Current changes in cash | -3.02%-20.39M | 98.94%-73.61K | 0.40%-5.31M | -87.29%-7.4M | -111.86%-7.61M | -21.96%-19.79M | -98.51%-6.92M | -54.29%-5.33M | 47.37%-3.95M | -101.83%-3.59M |
| End cash Position | -95.94%862.09K | -95.94%862.09K | -96.68%935.69K | -81.36%6.24M | -63.56%13.65M | -48.22%21.25M | -48.22%21.25M | -36.74%28.17M | -30.18%33.5M | -32.51%37.45M |
| Free cash flow | -3.53%-24.58M | 58.86%-4.49M | 4.65%-5.08M | -87.29%-7.4M | -114.69%-7.61M | -90.20%-23.74M | -228.32%-10.92M | -10.53%-5.33M | -54.59%-3.95M | -99.17%-3.54M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
